Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.

[1]  J. Curtsinger,et al.  Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis1 , 2005, The Journal of Immunology.

[2]  J. Sprent,et al.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.

[3]  K. Matsushima,et al.  Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs , 2005, The Journal of experimental medicine.

[4]  C. Meijer,et al.  Antigen Gene Transfer to Human Plasmacytoid Dendritic Cells Using Recombinant Adenovirus and Vaccinia Virus Vectors , 2005, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[5]  K. Conzelmann,et al.  Viruses know it all: new insights into IFN networks. , 2005, Trends in immunology.

[6]  J. Prieto,et al.  Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  R. Schreiber,et al.  A critical function for type I interferons in cancer immunoediting , 2005, Nature Immunology.

[8]  Osamu Takeuchi,et al.  Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.

[9]  J. Barrio,et al.  Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. , 2005, Gastroenterology.

[10]  A. Narbey.  Update on viral hepatitis. , 2005, Nursing times.

[11]  D. Larkin,et al.  Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. , 2005, Blood.

[12]  L. Platanias.  Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.

[13]  Giovanna Lombardi,et al.  Type I interferons and the innate immune response--more than just antiviral cytokines. , 2005, Molecular immunology.

[14]  A. Lok,et al.  Update on viral hepatitis in 2004 , 2005, Current opinion in gastroenterology.

[15]  P. Darcy,et al.  Gene modification strategies to induce tumor immunity. , 2005, Immunity.

[16]  E. Fish,et al.  Diversity and relatedness among the type I interferons. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[17]  G. Trinchieri,et al.  Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.

[18]  C. D. Krause,et al.  Interferons, interferon‐like cytokines, and their receptors , 2004, Immunological reviews.

[19]  J. Prieto,et al.  IFN-α5 Mediates Stronger Tyk2-Stat-Dependent Activation and Higher Expression of 2′,5′-Oligoadenylate Synthetase Than IFN-α2 in Liver Cells , 2004 .

[20]  C. Rinaldo,et al.  Virus infection of dendritic cells: portal for host invasion and host defense. , 2004, Trends in microbiology.

[21]  R. Hill,et al.  E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models , 2003, Nature Biotechnology.

[22]  J. Prieto,et al.  Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses , 2003, Journal of Virology.

[23]  N. Bhardwaj,et al.  Type I interferons promote cross-priming: more functions for old cytokines , 2003, Nature Immunology.

[24]  M. Magnusson,et al.  The Maturation of Murine Dendritic Cells Induced by Human Adenovirus Is Mediated by the Fiber Knob Domain* , 2003, Journal of Biological Chemistry.

[25]  P. Borrow,et al.  Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon , 2003, Nature Immunology.

[26]  Persephone Borrow,et al.  Viral infection switches non-plasmacytoid dendritic cells into high interferon producers , 2003, Nature.

[27]  J. Prieto,et al.  Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNγ-induced apoptosis , 2003, Gene Therapy.

[28]  Y. Takakura,et al.  Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  R. DeMatteo,et al.  Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection. , 2002, Cancer research.

[30]  Michael G. Katze,et al.  Viruses and interferon: a fight for supremacy , 2002, Nature Reviews Immunology.

[31]  Molecular therapy , 2002, Journal of the Neurological Sciences.

[32]  Yong‐jun Liu,et al.  Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.

[33]  T. Taniguchi,et al.  The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors , 2002 .

[34]  Marc Dalod,et al.  Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology , 2001, Nature Immunology.

[35]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[36]  J. Prieto,et al.  αvβ3 Integrin-Mediated Adenoviral Transfer of Interleukin-12 at the Periphery of Hepatic Colon Cancer Metastases Induces VCAM-1 Expression and T-Cell Recruitment , 2001 .

[37]  F. Belardelli,et al.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.

[38]  J. Prieto,et al.  Alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitment. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  C. Maliszewski,et al.  Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. , 2000, Blood.

[40]  A. Thomson,et al.  Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-κB-Dependent Pathway , 2000, Journal of Virology.

[41]  D. Levy,et al.  Distinct Requirements for IFNs and STAT1 in NK Cell Function1 , 2000, The Journal of Immunology.

[42]  L. Falo,et al.  Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo. , 2000, Human gene therapy.

[43]  A. Enk,et al.  Dendritic cell‐based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti‐melanoma immunity , 1999, The journal of gene medicine.

[44]  J. Prieto,et al.  Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas , 1999, Gene Therapy.

[45]  P. Liljeström,et al.  Two-Helper RNA System for Production of Recombinant Semliki Forest Virus Particles , 1999, Journal of Virology.

[46]  R. Roberts,et al.  The Evolution of the Type I Interferons1 , 1998 .

[47]  R. Khan,et al.  Update on Viral Hepatitis , 1997, Journal of the Royal College of Physicians of London.

[48]  K. Anderson,et al.  Adenovirus early region 1A modulation of interferon antiviral activity , 1987, Journal of virology.

[49]  G. Trinchieri,et al.  Production of type I interferons: plasmacytoid dendritic cells and beyond , 2005 .

[50]  Yong‐jun Liu,et al.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.

[51]  J. Prieto,et al.  IFN-alpha5 mediates stronger Tyk2-stat-dependent activation and higher expression of 2',5'-oligoadenylate synthetase than IFN-alpha2 in liver cells. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[52]  T. Michiels,et al.  Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. , 2003 .

[53]  T. Taniguchi,et al.  The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. , 2002, Current opinion in immunology.

[54]  R. Alemany,et al.  A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[55]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[56]  R. Roberts,et al.  The evolution of the type I interferons. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[57]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .